Interatrial Shunt Devices Market – By Product Type, By Application, By End Use – Global Forecast, 2025 - 2034

Interatrial Shunt Devices Market Size

The global interatrial shunt devices market size was valued at around USD 3.8 billion in 2024 and is estimated to grow at 7% CAGR from 2025 to 2034. An interatrial shunt device is a medical device designed to create a controlled passage (or shunt) between the left atrium and the right atrium of the heart. This shunt allows blood to flow between the two atria, typically to reduce pressure imbalances or improve cardiac efficiency in specific medical conditions. These devices are often used to treat patients with certain forms of heart failure or pulmonary hypertension.
 

The market is primarily driven by the increasing prevalence of heart failure worldwide. According to the Journal of Cardiac Failure, nearly 6.7 million American aged over 20 years suffer from heart failure. The number is further estimated to increase to reach 8.5 million by 2030. As the global population ages and lifestyle-related risk factors become more common, the incidence of heart failure continues to rise. Interatrial shunt devices offer a minimally invasive treatment option for patients with heart failure, particularly those with preserved ejection fraction (HFpEF). These devices provide an alternative to traditional pharmacological therapies, which may have limited efficacy in certain patient populations.
 

Moreover, ongoing technological advancements in interatrial shunt devices are contributing to market growth. Improved device designs, materials, and implantation techniques are enhancing the safety and efficacy of these treatments. Additionally, the expanding body of clinical evidence supporting the use of interatrial shunt devices is increasing physician confidence and adoption rates. As more long term data becomes available and regulatory approvals are obtained in various regions, the market for these devices is expected to expand further, driving growth in the coming years.
 

Interatrial Shunt Devices Market Trends

The market is witnessing a surge in clinical trials and research activities. Several companies are conducting studies to evaluate the safety and efficacy of these devices in treating heart failure patients. This trend is expected to generate more robust clinical evidence, potentially leading to wider adoption of interatrial shunt devices in clinical practice.
 

• Manufacturers are increasingly focusing on developing smaller, less invasive interatrial shunt devices. This trend towards miniaturization aims to reduce procedural complexity, minimize patient discomfort, and potentially improve outcomes. Smaller devices may also expand the eligible patient population, driving market growth.
   
• There is a growing trend towards the use of advanced materials in interatrial shunt devices. Manufacturers are exploring biocompatible materials that can enhance device durability, reduce the risk of complications, and improve long-term outcomes. This focus on material innovation is expected to contribute to the overall advancement of interatrial shunt technology.
   
• The market is experiencing geographical expansion, with companies seeking regulatory approvals in new regions. This trend is particularly evident in emerging markets, where the prevalence of heart failure is increasing. As regulatory barriers are overcome and awareness grows, these new markets are expected to contribute significantly to the overall market growth.
   
• There is a growing trend towards personalized treatment approaches in the market. Manufacturers are developing devices that can be tailored to individual patient anatomy and specific heart failure conditions. This customization aims to improve treatment outcomes and patient satisfaction.
   
• The integration of telemedicine in patients follow-up and monitoring is emerging as a significant trend. Remote monitoring capabilities are being incorporated into interatrial shunt devices, allowing healthcare providers to track patient progress and device performance without frequent in-person visits. This trend is expected to improve patient care and reduce healthcare costs.
   
• The use of artificial intelligence (AI) in conjunction with interatrial shunt devices is an emerging trend. AI algorithms are being developed to assist in patient selection, optimize device settings, and predict potential complications. This collaboration between AI and medical devices is expected to enhance treatment efficacy and patient outcomes in the market.
   

Interatrial Shunt Devices Market Analysis

Based on product type, the market is segmented into balloon expandable devices, self-expanding devices, and other product types. The balloon expandable devices dominated the market with the largest revenue of USD 2.1 billion in 2024 and is expected to grow at a significant CAGR over the forecast period.
 

• Balloon expandable interatrial shunt devices are gaining market dominance due to their unique advantages in deployment and positioning. These devices offer precise placement and controlled expansion, allowing physicians to adjust the size of the shunt during the procedure. This flexibility enables optimal sizing for each patient's anatomy, potentially reducing complications and improving outcomes.
   
• Additionally, the balloon expandable mechanism also provides enhanced stability post-deployment, reducing the risk of device migration. This feature is particularly crucial in maintaining long-term efficacy of the shunt. Moreover, the balloon expandable design often allows for a smaller delivery profile compared to self-expanding alternatives, potentially simplifying the implantation procedure and expanding the patient population eligible for treatment.
   
• Also, balloon expandable devices typically offer better radial strength, which can be advantageous in maintaining shunt patency over time. This characteristic, combined with the ability to achieve a more predictable final diameter, contributes to the growing preference for balloon expandable interatrial shunt devices among interventional cardiologists, leading to market growth.
   

Based on application, the interatrial shunt devices market is segmented into heart failure management, pulmonary hypertension treatment and other applications. The heart failure management segment of the market, which held a 68.9% share in 2024, is poised for substantial growth in the coming years.
 

• The high usage of interatrial shunt devices in heart failure management is primarily driven by their ability to address a critical unmet need in patients with heart failure with preserved ejection fraction (HFpEF). These devices effectively reduce left atrial pressure, which is a key factor in symptom improvement for HFpEF patients. Traditional pharmacological treatments often have limited efficacy in managing this condition, making interatrial shunt devices an attractive alternative. The rising prevalence of HFpEF, especially among older populations, has further increased the demand for these innovative treatment options.
   
• Technological advancements in interatrial shunt devices have also contributed to their widespread use in heart failure management. Improved device designs and implantation techniques have resulted in better patient outcomes and reduced procedural complications. These enhancements have increased physician confidence in recommending and utilizing these devices, further solidifying their position as a dominant treatment option in the global heart failure management market.
   

Based on end use, the interatrial shunt devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and other end users. The hospitals segment of the market, which held a 54.8% share in 2024, is poised for substantial growth in the coming years.
 

• The increasing prevalence of heart failure and the growing elderly population are significant drivers for the high usage of interatrial shunt devices in hospitals. For instance, according to the World Health Organization’s statistics, the number of people aged above 60 years is anticipated to nearly double from 12% in 2015 to 22% by 2050.
   
• As these conditions become more common, hospitals are adopting advanced treatment options, including interatrial shunt devices, to manage complex cardiac cases effectively. The ability of these devices to reduce left atrial pressure and improve symptoms in heart failure patients has made them a preferred choice in hospital settings.
   

The U.S. dominated the North American interatrial shunt devices market with revenue of USD 1.1 billion in 2024 and is projected to witness substantial growth over the forecast period.
 

• The U.S. leads the North America market, primarily due to its advanced healthcare infrastructure and high prevalence of cardiovascular diseases. For instance, according to CDC data, around 702,880 people died due to heart disease in 2022 in the U.S.
   
• Moreover, the country's robust research and development capabilities, coupled with significant investments in medical technology, have resulted in innovative interatrial shunt devices.
   
• These factors contribute to the widespread adoption of these devices in U.S. hospitals.
   

The interatrial shunt devices market in the UK is expected to experience significant growth from 2025 to 2034.
 

• The UK’s healthcare system's emphasis on minimally invasive procedures and improved patient outcomes has driven the demand for interatrial shunt devices.
   
• Further, favorable reimbursement policies for cardiovascular procedures coupled with rising incidence of cardiovascular ailments such as pulmonary arterial hypertension supports market growth. For instance, according to the British Heart Foundation, presently nearly 7.6 million people in the UK suffer from heart and circulatory diseases.
   
• The increasing aging population and rising awareness about heart failure treatments also contribute to the expanding use of these devices in the UK.
   

The Asia Pacific interatrial shunt devices market is anticipated to witness lucrative growth between 2025 and 2034.
 

• The Asia Pacific market is primarily driven by the increasing prevalence of heart failure and related cardiovascular disorders in the region. For instance, according to Biomedical and Environmental Sciences Journal, around 330 million people in China suffered from cardiovascular diseases of which 8.9 million suffered from heart failure.
   
• As populations age and lifestyle-related risk factors become more common, the demand for innovative treatments like interatrial shunt devices is expected to rise.
   
• Additionally, growing awareness among healthcare professionals and patients about the benefits of minimally invasive procedures for heart failure management contributes to market growth.
   

The interatrial shunt devices market in Saudi Arabia is expected to experience significant growth from 2025 to 2034.
 

• The Saudi Arabian market is primarily driven by the increasing prevalence of cardiovascular diseases, particularly congenital heart defects. As awareness of these conditions grows and diagnostic capabilities improve, more cases are being identified, leading to a higher demand for interatrial shunt devices.
   
• Additionally, the Saudi government's focus on enhancing healthcare infrastructure and services has resulted in better access to advanced medical treatments, including those involving interatrial shunt devices. Thereby, leading to overall market growth.
   

Interatrial Shunt Devices Market Share

The market is characterized by intense competition among key players such as Corvia Medical, Johnson & Johnson, and Occlutech. These companies are focusing on innovative product development and strategic partnerships to gain a competitive edge. The market is driven by the increasing prevalence of heart failure and the growing demand for minimally invasive treatment options. Regulatory approvals play a crucial role in market success, with companies investing heavily in clinical trials to demonstrate device safety and efficacy.
 

Moreover, regional expansion and distribution agreements are common strategies employed by market players to increase their global footprint. Emerging players are also entering the market with novel technologies, further intensifying competition. As the market is still in its early stages, companies are striving to establish themselves as leaders through technological advancements, patent protection, and strategic collaborations with healthcare providers and research institutions.
 

Interatrial Shunt Devices Market Companies

Some of the eminent market participants operating in the interatrial shunt devices industry include:

• Adona Medical
• Alleviant Medical
• BioVentrix
• Corvia Medical
• CryoLife
• Edwards Lifesciences
• Gore Medical
• InterShunt Technologies
• Johnson & Johnson
• Lepu Medical
• Medtronic
• Micro Interventional Devices
• Occlutech
• Venus Medtech
• Wuhan Weike Medical Technology
   

Interatrial Shunt Devices Industry News:

• In October 2024, Johnson & Johnson completed acquisition of V-Wave, company engaged in development of innovative treatment options for heart failure patients. The acquisition strengthened Johnson & Johnson’s cardiology solutions portfolio as well as broadened its consumer base.
   

The interatrial shunt devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Balloon expandable devices
• Self-expanding devices
• Other product types          

Market, By Application

• Heart failure management
• Pulmonary hypertension treatment
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end users  

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE